• OPEN AN ACCOUNT
Indian Indices
Sensex
78,499.17 -455.59
( -0.58%)
Global Indices
Nasdaq
53,904.84 -465.28
(-0.86%)
Dow Jones
7,729.00 -15.55
(-0.20%)
Hang Seng
65,597.55 -85.71
(-0.13%)
Nikkei 225
10,873.25 -15.05
(-0.14%)
Forex
USD-INR
95.07 -0.16
(-0.17%)
EUR-INR
109.74 0.07
(0.06%)
GBP-INR
127.99 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Nectar Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532649
INE023H01027
29.975455
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NECLIFE
0
201.84
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Apis India consolidated net profit rises 27.31% in the March 2026 quarter
Jun 01,2026
Net profit of Apis India rose 27.31% to Rs 10.35 crore in the quarter ended March 2026 as against Rs 8.13 crore during the previous quarter ended March 2025. Sales rose 8.57% to Rs 97.89 crore in the quarter ended March 2026 as against Rs 90.16 crore during the previous quarter ended March 2025.

For the full year,net profit declined 0.08% to Rs 25.32 crore in the year ended March 2026 as against Rs 25.34 crore during the previous year ended March 2025. Sales rose 11.46% to Rs 390.51 crore in the year ended March 2026 as against Rs 350.35 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales97.8990.16 9 390.51350.35 11
OPM %7.8012.00 -9.169.61 -
PBDT10.2110.45 -2 37.1932.51 14
PBT8.919.21 -3 32.4828.57 14
NP10.358.13 27 25.3225.34 0